PLA2G7 and Stroke: The loss-of-function variant of PLA2G7 V279F was not associated with components of MVE: total stroke (5967 events; 1.00, 0.92–1.09); myocardial infarction (653 events; 0.91, 0.71–1.17); and vascular death (2139 events; 0.92, 0.80–1.06).